Background: Infantile colic is a frequent problem in neonates and infants. This review addresses current management including the results for nutrient modifications; soybased formulas; and prebiotics, probiotics, and synbiotics.
| DEFINITION, CRITERIA, AND CAUSES OF INFANTILE COLIC
Infantile colic (IC) often results in excessive crying and accounts for 10-20% of pediatrician visits of infants aged 2 weeks to 3 months. 1 In 2001, it was reported to cost the United Kingdom National Health Service in excess of £65 million per year.
2 Infantile colic is a syndrome characterized by paroxysms of irritability and inconsolable crying and screaming, accompanied by clenched fists, drawn-up legs, and a red face. It presents typically in the second or third week after birth, and peaks at 5-8 weeks of age; it usually resolves spontaneously by 4 months of age. The prevalence is estimated to be between 5% and 28%. 1 The currently used diagnostic criteria for IC are the Rome IV criteria, which include all of the followings: (i) paroxysms of irritability with fussing or crying that start and stop without obvious causes; (ii) symptoms lasting ≥3 hours a day and occur ≥3 days a week for ≥1 week; (iii) absence of failure to thrive, in infants from birth to 5 months of age. 1 These criteria are adapted from the "Rule of Three" originally proposed by Wessel et al.
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: 3 hours per day, ≥3 days per week, ≥3 weeks. An underlying organic cause for the colic is found in less than 5% of these infants. Thus, it is usually benign and self-limiting. 4 Pathogenesis of IC is still unclear, but it has been associated with different causes, such as alterations in intestinal microflora and gut hormones, gas production, allergy to cow's milk proteins, behavioral problems (e.g. family tension and parental anxiety), increasing maternal age, first born status and maternal smoking. 5 Moreover, it is also possible that IC represents the last stage of the physiological developmental "crying curve" of healthy infants, with no evidence that the crying is caused by pain in the abdomen or any other part of the body. 1 Given these diverse associations, it is not surprising that treatment is non-specific and not driven by data.
| CURRENT APPROACHES TO TREATMENT OF IC
In this section, we will summarize the findings of several systematic or narrative reviews that evaluated the different types of pharmacological, nutritional, and behavioral interventions available for the treatment of IC. The role of probiotics, prebiotics, and synbiotics is discussed in the section on the hypothesis of alterations in the microbiota.
| PHARMACOLOGICAL APPROACHES
Hall et al. 5 and Lucassen 6 systematically reviewed literature on treatments for IC. Considering pharmacological treatment, two different randomized controlled trials (RCTs) found no difference when simethicone, which prevents gas bubbles from forming in the gastrointestinal tract, was compared to placebo. 7, 8 On the contrary, one RCT found simethicone to be effective in the management of crying attacks.
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Nonetheless, this study was of poor-quality and the definition of colics was not clear. 6 Regarding dicyclomine hydrochloride, an anticholinergic agent with a relaxing effect on smooth muscle, two different RCTs 10, 11 found favorable results on crying time. However, due to reported side effects, such as dyspnea, respiratory collapse, apnea, asphyxia, pulse rate fluctuations, and muscular hypotonia, this drug is not approved for use in infants younger than 6 months of age. 5 Finally, the last drug assessed for the management of IC is cimetropium bromide, a muscarinic antagonist with direct spasmolytic activity. There is only one RCT available, and the authors describe a significant decrease in the duration of colic episodes with cimetropium bromide compared to placebo. 12 However, an increase in sleepiness is reported, and the level of evidence is poor because of methodological fails. 6 Due to the uncertain efficacy for the management of IC and considering the possible adverse effects, this drug has never been approved for use in the U.S. and Canada. In conclusion, pharmacological treatment is not recommended for the management of infants with colics.
| NUTRITION MODIFICATION
Numerous studies have evaluated the efficacy of hydrolyzed formulas in bottle-fed infants or low-allergen maternal diets in breastfed infants. The effect of casein hydrolysate milk has been evaluated in several studies. In a recent review, Lucassen 13 identified two RCTs that demonstrated an effect of this intervention on infant distress and crying time. The first study from Hill et al. 14 compared the effects of maternal hypoallergenic diet/casein hydrolysate formula to standard care (breast milk or cow's milk formula), and found a significant reduction in infants' distress level in the active diet group compared to the standard care group. In the second study, 15 Arikan et al. found that an hydrolyzed formula administered for 7 days was effective in reducing the duration of crying in colicky infants, compared with baseline.
Nevertheless, for both studies, the level of evidence is very low, due to weak methods or incomplete reporting of the data. 13 Moreover, a study by Jakobsson et al. 16 highlighted a reduction in crying duration using two types of casein hydrolyzed formulas vs cow's milk formula, while Forsyth 17 found no significant difference between casein hydrolysate and cow's milk formula. In addition, for these two last studies the level of evidence is poor due to unclear randomization and lack of calculation of patients needed to treat. 5 Similarly, another RCT 18 compared whey hydrolysate milk to cow's milk formula, and showed a reduction in crying from baseline.
Yet, the quality of evidence is low due to unmasked blinding. Another study 19 highlighted a reduction in the number of colic episodes using a partially hydrolyzed whey formula with oligosaccharides, B-palmitic acid, and low lactose. Nevertheless, the presence of several modified ingredients makes it difficult to evaluate the effects of whey hydrolysate alone.
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Considering all the aforementioned evidence, the recommendation is to avoid changes in the type of formula if the child is thriving.
However, in a selected subset of formula-fed infants, such as children with atopy, a trial with a hypoallergenic formula may be an effective treatment for IC, 20, 21 though it is important to highlight that this suggestion is not based on evidence from RCTs, but on clinical reasoning.
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The benefits of soy-based formulas in treatment of IC are not supported by evidence of sufficient quality. 13 In addition, due to the high phyto-estrogen content that may affect long-term reproductive health, soy-based formulas are not recommended for use in healthy infants and should not be used during the first 6 months of life, as stated by the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition Committee on Nutrition.
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The use of low-lactose milk or high-fiber formula is ineffective and is not supported by evidence of sufficient quality.
5, 13
| Summary of nutrition modification
Changes in infant formula are often tried based on assumption that there may be intolerance or allergy, but this is seldom present, and it is important to emphasize avoiding changes in the type of formula if the child is thriving and only consider a hypoallergenic formula if there is evidence of atopy.
| BEHAVIORAL APPROACHES
Chiropractic manipulation helps some patients, but may be no more effective than a nurse's cuddling for 10 minutes. In a meta-analysis, when combining only those trials with a low risk of such performance bias, the results of manipulation did not reach statistical significance.
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Key Points Moreover, a case of death after manipulation of the cervical and thoracolumbar spine in a 3-months-old infant is reported. For this reason, considering the lack of evidence of safety and effectiveness, manipulation of the vertebral column is not recommended.
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The advice to increase carrying, 24 to reduce stimulation of the child by not lifting and patting the baby, 25 to use a car ride simulator or the counseling of the mother about specific management techniques 26 are not proven to be effective, and the level of quality of evidence is low.

| SUMMARY OF THE EVIDENCE
It is important to highlight that a recent systematic review from Steutel et al. 27 showed a general lack of agreement about definitions, primary outcome measures, and instruments used in intervention trials on IC.
Therefore, this lack of uniformity makes it difficult to evaluate and 
| HYPOTHESES
Given the prevailing timing of IC, which presents typically in the second or third week after birth, peaks at 5-8 weeks of age, and usually resolves spontaneously by 4 months of age, we explored three hypotheses:
Firstly, immaturity of hepatic synthesis, reduced intraluminal levels of bile acids, and impaired ileal absorption of bile acids in the neonate result in malabsorption of fat and other nutrients, with potential for secondary effects on colonic microbial flora.
Secondly, the colonic microbial flora are abnormal and result in increased nutrient fermentation and reduced levels of dehydroxylated bile acids in the colon.
Thirdly, immaturity of the enteric nervous system (ENS) leads to abnormal motor and sensory functions of the intestine and colon.
Overall, the literature provides evidence for interaction among these three mechanisms, and this review highlights the interplay among these mechanisms and the potential for their identification that may lead to novel approaches to the management of IC.
| LITERATURE SUPPORTING THE HYPOTHESIS OF BILE ACID IMMATURITY
There are several elements in the enterohepatic circulation that are immature in the neonate, based on animal and human studies. The evidence is summarized here:
| Abnormal levels and composition of bile in the alimentary tract and serum
Reductions in bile salt pool size, synthesis, and intestinal concentrations have been demonstrated in neonates 28, 29 ; maturity may be influenced by dexamethasone or phenobarbital administered to the mother prior to delivery. In addition, Kawasaki et al. 30 showed that serum concentrations of primary and total bile acids increased gradually in the neonatal period, with peak serum levels reached at 1 month of age, with predominance of primary serum bile acids by 3 months of age, with a significant increase in the primary total bile acid ratio by 5 months of age and declining to the ratios observed in adults by 4-6 years of age.
| Fasting duodenal aspirate bile acid
Measurements of fasting duodenal aspirate bile acid showed higher cholic acid (CA) to chenodeoxycholic acid (CDCA) ratio and higher glycine to taurine conjugates of the bile acids (both being 3-alpha-hydroxy bile acids) at younger postnatal age in human milk-fed preterm infants. 31 These data suggest immaturity in the alternative pathway of bile acid synthesis, which requires 27 alpha hydroxylase steps in the biosynthesis from cholesterol. In addition, the increased glycine conjugation suggests failure of peroxisomal function, as the normal ratio of conjugates is 3:1 (glycine to taurine). Interestingly, there is a decline in the ratio of CA to CDCA and glycine to taurine conjugate ratio in most infants within about 4-5 months, which corresponds to the timing of resolution of IC.
| Fetal gallbladder bile
Profiles (collected postmortem) of fetal gallbladder bile are similar to those in the intestine with the exception of sulfate conjugates 32 and the proportion of deoxycholic acid (DCA). Thus, one study noted that DCA was notably absent from the bile of infants and some children, 33 and this may suggest that the dehydroxylation of CA by colonic bacteria may have contributed to the absence of DCA in the gallbladder bile; however, this was based on bile from gallbladders obtained postmortem from 30 human subjects rather than from otherwise healthy subjects.
The significance of this finding relative to intestinal colic is unclear, although studies in infants and children with inborn errors of bile acid metabolism (such as defects in amidation) may present with fat-soluble vitamin deficiency 34 and illustrate the potential role of immaturities in bile acid synthesis in the neonate.
| Immaturity in hepatic synthesis of bile acids
Immaturity in hepatic synthesis of bile acids is supported by evidence of abnormal levels of nuclear receptors in developing rat hepatocytes. 35 Thus, bile acid transporters (FXR, PXR, LXR-alpha, PPARalpha, RAR-alpha, LRH1, and SHP) involved in bile acid formation are poorly developed in the fetal stage, but their expression gradually matures postnatally and reaches adult levels by 4 weeks of age. This immaturity of hepatic synthesis might therefore be a factor in the IC observed in the first 4 weeks postnatally, but may be one of the factors that initiates the cascade of events leading to IC observed after 4 weeks of age.
| Immaturity in intestinal absorption of bile salts
In a series of landmark studies, Lester et al. investigated immaturity in intestinal absorption of bile salts. They showed that the ileal mechanism for active transport of taurocholate was undeveloped in the fetus and newborn infant, leading to the conjecture that enterohepatic circulation of bile salt during the perinatal period is limited to that fraction of bile salt absorbed passively, thus resulting in loss of bile salt from the immature intestine that may contribute to steatorrhea and to the "diarrhea" of newborn infants 36, 37 ; similar findings were observed in dogs. 38 Lester 39 drew attention to the analogy between immaturity of bilirubin conjugation and excretion in neonatal jaundice that resolves itself in a few days, and immaturity in bile acid production and function, that resolves in a few weeks. 
| Steatorrhea in neonatal period
40
In addition, steatorrhea often occurs during the first month, and decreases during the first postnatal month (as shown by the fall in the steatocrit curve from 7th to 28th day) and, by 45 days, few babies have steatorrhea.
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In the next section, we discuss the potential relationship between changes in bile acids and the microbiome, to which one can also add the potential that steatorrhea in the neonate could result in additional perturbation that may lead to IC, for example in the presence of high concentrations of fatty acids or bile acids in the infant's colon. Although such studies have not been conducted in infants or children, it has been demonstrated in adults that higher concentrations of long chain and short chain fatty acids, and even relatively low concentrations of the bile acid, CDCA (1 mM infused into the distal colon), can induce high amplitude propagated contractions 42, 43 that are frequently sensed or may be associated with pain.
| LITERATURE SUPPORTING MICROBIAL ALTERATIONS IN THE NEONATE
Immediately after birth, a diverse flora of staphylococci, streptococci, enterococci, and enterobacteriaceae colonizes the sterile gut.
Anaerobic 
| Association of changes in microbiota and IC
In earlier studies, colicky infants were more frequently colonized with Clostridium difficile during the time of colic than were the agematched controls; this difference disappeared by age 3 months, when it was noted that stool fatty-acid profiles were different between the infants who had suffered from severe colic and the control infants. The fatty-acid profiles were also influenced by the age of the infant, the mode of delivery, antimicrobial drugs taken by the mother during delivery, and breast-feeding and type of feeding. 52 Fecal samples were found to have higher counts of coliform bacteria and lower counts of lactobacilli in infants with colic symptoms compared with children not suffering from colic 53, 54 ; moreover, different colonization patterns of lactobacilli were found among colicky and healthy infants: Lactobacillus brevis and L. lactis were found only in colicky infants, whereas L.acidophilus was found only in healthy infants. 55 Interestingly, L. delbrueckii subsp. delbrueckii DSM 20074
and L. plantarum MB 456 had antimicrobial effects against six species of gas-forming coliforms isolated from colicky infants. 56 These interesting studies on different Lactobacillus species need replication by other research groups.
In other studies, Klebsiella species were more prevalent in colic patients than in control patients, whereas Enterobacter/Pantoea species were detected only in the control patients; in the same study, fecal calprotectin levels were twofold higher in infants with colic than in control infants. 57 The proportion of Bifidobacterium counts to total bacterial counts and to a lesser extent, the frequency of Lactobacillus spp. at the age of 3 weeks were inversely associated with the amount of crying and fussing during the first 3 months. 58 A probiotic Bifidobacterium breve B632 species inhibited growth of gas-forming Enterobacteriaceae in fecal microbiota cultures from a colicky infant. 59 Using phylogenetic microarray for studying the human gastrointestinal microbiota (the human intestinal tract chip [HITChip] assay), infants with colic showed lower microbial diversity and stability than control infants in the first weeks of life; there were also differences in the abundance of certain bacteria at 2 weeks suggesting that microbial signatures may explain the colic phenotype. 60 The colic phenotype correlated positively with specific groups of proteobacteria, including bacteria related to Escherichia, Klebsiella, Serratia, Vibrio, Yersinia, and Pseudomonas, but negatively with bacteria belonging to the Bacteroidetes and Firmicutes phyla. The latter phyla include some lactobacilli and canonical groups known to produce butyrate and lactate.
61
It has been postulated that early increased levels of pathogenic bacteria and reductions of lactobacilli, bifidobacteria or butyrateproducing bacteria produce intestinal pain and inflammation in the infant, and that this in turn causes excessive crying. 
| Trials of prebiotics, probiotics and synbiotics in IC
Given the potential effects of prebiotics, probiotics, and synbiotics on intestinal motility and sensory neurons, contractile activity of the intestine, anti-inflammatory effects and alterations of the microbiome, several studies have explored their potential clinical benefit (Tables 1 and 2) 63-71 and have also been evaluated in three recent systematic reviews. [72] [73] [74] Although Lactobacillus reuteri may be effective as a treatment strategy for crying in exclusively breastfed infants with colic, the evidence supporting probiotic use for the treatment of IC or crying in formula-fed infants remains unresolved. The administration of L. reuteri DSM 17938 at a dose of 10 8 CFU once a day appears to reduce crying times in infants with IC, especially in exclusively or predominantly breastfed infants. [72] [73] [74] Nevertheless, these industry-sponsored trials require replication, particularly in formulafed patients.
| Relationship of microbiome to bile acids
Perturbations of the microbiota shape the bile acid pool and modulate the activity of bile acid-activated receptors. Bile acids, in turn, can also regulate the composition of the gut microbiome at the highest taxonomic levels. 75 Several molecules made or modified by the microbiota including short-chain fatty acids, succinate, mucin O-glycans, secondary bile acids, and the AI-2 quorum sensing auto-inducer affect the growth and virulence of pathogens. ], abnormal motor repertoire associated with prematurity, and potential therapeutic approaches to normalize the dysfunction.
| Ontogeny of neural control of intestinal motility
The 
| Evidence of immature small intestinal motility
The Berseth group conducted an extensive series of studies of antral and small intestinal motility in preterm and term infants.
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| Duodenal motility patterns
In preterm and term infants, dudodenal motility patterns differ.
Intestinal motor characteristics are more immature in preterm than 
| Antral motility
Antral motility consists of isolated single contractions and clustered phasic contractions in term and preterm infants, with no differences in the occurrence or amplitude of antral activity between the two groups of infants and with no change in antral motor activity with advancing gestational age. 79 The proportion of antral clusters that was temporally associated with duodenal activity was significantly lower in preterm infants than in term infants (P<.001). Moreover, the degree of association of antral and duodenal activity increased significantly with gestational age.
These data show that fasting antral motor activity is comparable in preterm and term infants, and the temporal coordination of antral and duodenal activity develops in association with progressive changes in duodenal motor activity in the preterm infant. One way to enhance the functional maturation of these motor functions is enteral feeding.
Thus, early-fed infants were able to tolerate full oral nutrition sooner, had fewer days of feeding intolerance, and had shorter hospital stays in preterm infants. 81 This is also achieved with intragastric feeding, 79 and the effect is specific for motor, rather than mucosal, maturation.
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In part, this maturation is also enhanced by the postnatal development of gut neuroendocrine signals. 80 Thus, fasting plasma gastrin and peptide YY levels were low in the preterm human (n=19) and canine neonate during the first postnatal week, but the plasma levels of both increased with postnatal age. Motor quiescence during fasting (in contrast to the excessive incoordinated contractile activity manifested as clustered phasic contractions) becomes a more prominent feature of newborn intestinal motor functions postnatally. 75 The inhibition of this contractile activity appears to coincide with the level of peptide YY, which generally reduces contractile activity and is a major factor in mediating the ileal brake in the mature gut. 83, 84 Conversely, the motilin receptor agonist, erythromycin, is able to induce phase III migrating motor complexes after 32 weeks' gestation, suggesting that early use of erythromycin as a prokinetic agent may not be useful in early preterm infants, may be partially useful in older preterm infants, and may be most useful in full-term infants. 85 Finally, the relevance of the maturation of the motor repertoire is confirmed by experience
showing that assessment of intestinal motility serves as a useful clinical guide in the feeding management of the newborn. 86 These observations provide the basis for the hypothesis that enteric motor immaturity may conceivably result in infantile colic.
| THERAPEUTIC OPPORTUNITIES FOR IMMATURITY OF MOTOR FUNCTION
The extrinsic parasympathetic and sympathetic nerves serve to modulate the preprogrammed functions controlled by the ENS. The peristaltic reflex involves an afferent component that is mediated by intrinsic primary afferent neurons, ascending contractions (e.g., cholinergic
and tachykininergic neurons), and descending relaxation (nitrergic or vasoactive intestinal peptidergic neurons). The observation of normal variability in heart rate in children with colic suggests that extrinsic parasympathetic control of viscera is normal. 87 Overall, the hypothesis that IC may be a disorder of gastrointestinal motor function requires further support through measurements of motility in infants with IC.
Meanwhile, the studies of the ontogeny of the enteric neural control and maturation of the repertoire in small intestinal motility provide support for the concept that dysregulation and immaturity of intestinal motility contribute to the development of infantile colic. 88, 89 Irrespective of the precise mechanism, there appears to be incoordination or spasm of intestinal motility, and this has led to the use of antispasmodic drugs, such as dicyclomine 11 or cimetropium bromide,
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which are generally muscarinic cholinergic antagonists. In addition, development of interdigestive migrating motor complexes appears to be associated with relief of colic. Such complexes are associated with high motilin levels. 90, 91 Beneficial effects are reported with some herbal teas, such as fennel, lemon balm and chamomile, or with phytotherapeutic agents, 92, 93 though the mechanisms and potential effects of all of these therapies on motor incoordination are unclear.
| POTENTIAL INTERACTIONS BETWEEN THREE HYPOTHETICAL MECHANISMS IN INFANTILE COLIC AND CONCLUSION
Overall, the literature provides evidence for interaction among these three mechanisms, and this review highlights the interplay among these mechanisms and the potential for their identification that may lead to novel approaches to the management of infantile colic.
The immaturity of hepatic bile acid synthesis, intraluminal levels, and ileal absorption of bile acids in the neonate result in malabsorption of fat, with potential for secondary effects on colonic microbial flora.
The latter changes may result in increased nutrient fermentation and reduced levels of dehydroxylated bile acids in the colon, where the contractile activities may be significantly altered, based on studies of the effects of primary (dehydroxylated) bile acids in the human adult colon exposed to estimated loads of ~1 mM chenodeoxycholate.
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These levels are likely to be achieved in the neonatal colon. However, no such studies are available to assess whether the immaturity of the ENS and the increase in intracolonic bile acid and fat content increases the propensity to abnormal motor and sensory functions of the intestine and colon in the neonate or infant with IC. Further research on these three, potentially interacting mechanisms may lead to novel approaches to more specific diagnosis and management of infantile colic.
Thus, with the availability of noninvasive tests that assess hepatic synthesis of bile acids (serum 7αC4), 94 gastric emptying in neonates using breath test measurements, 95 and stool microbiome studies (including phylogenetic microarray by HITChip assay), it is conceivable that there may be opportunities for individualizing therapy based on objective biomarker(s) in infants whose colic does not respond to the customary first line therapies.
